|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,390 JPY | -0.79% |
|
-0.28% | -11.64% |
| Apr. 12 | Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months | MT |
| Apr. 12 | COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024 | CI |
COSMOS Pharmaceutical Corporation provided earnings Forecast for the Fiscal Year Ending May 31, 2023. For the period, The company expects Net sales of JPY 813,500 million. Operating profit of JPY 30,000 million.
Profit attributable to owners of parent of JPY 23,200 million. Basic earnings per share of JPY 585.87.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.64% | 3.62B | |
| -0.09% | 3.36B | |
| -23.44% | 3.06B | |
| +7.56% | 2.67B | |
| +7.46% | 2.59B | |
| -9.26% | 1.75B | |
| +9.30% | 1.35B | |
| -20.60% | 957M | |
| -38.42% | 704M | |
| -1.85% | 370M |
COSMOS PHARMACEUTICAL CORPORATION 
